Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer,Cancer Medicine

当前位置： X-MOL 学术 › Cancer Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
Cancer Medicine ( IF 2.9 ) Pub Date : 2021-01-15 , DOI: 10.1002/cam4.3691
Mikko Loukovaara ₁ , Annukka Pasanen ₂ , Ralf Bützow _{1,

2}

Affiliation

Mismatch repair (MMR) system has been implicated in the response of mammalian cells to ionizing radiation and DNA damaging agents. We investigated the value of the MMR system in predicting response to adjuvant therapy in endometrial cancer.

中文翻译：